Autologous bone marrow stem cell transplant in acute myocardial infarction

Muhammad Masudul Hassan Nuri1, Shahid Hafeez

  • 1Department of Cardiology, Army Medical College, Rawalpindi.

Insights

Autologous bone marrow stem cell transplant improved clinical symptoms, left ventricle ejection fraction, and myocardial perfusion in patients with anterior myocardial infarction. This therapy appears safe and effective for post-heart attack recovery.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Interventional Cardiology

Background:

  • Recent anterior myocardial infarction (MI) significantly impacts left ventricle (LV) function and myocardial perfusion.
  • Limited therapeutic options exist to improve cardiac function post-MI.

Purpose of the Study:

  • To evaluate the efficacy of autologous bone marrow stem cell transplantation in patients with recent anterior MI.
  • To assess the impact on clinical symptoms, LV ejection fraction (LVEF), and myocardial perfusion.

Main Methods:

  • 26 male patients with anterior MI underwent autologous bone marrow stem cell transplantation into the damaged myocardium.
  • Stem cells were harvested from iliac crests and delivered via a stop-flow technique.
  • Efficacy was assessed by comparing clinical status, LVEF, and myocardial perfusion at baseline and 12 weeks post-transplant.

Main Results:

  • Significant improvement observed in general well-being.
  • Left ventricle ejection fraction showed notable enhancement post-transplantation.
  • Myocardial perfusion demonstrated positive changes following stem cell therapy.

Conclusions:

  • Autologous bone marrow stem cell transplantation is a safe and favorable treatment for improving post-MI LVEF and perfusion.
  • Further large-scale, randomized controlled trials are needed to confirm the efficacy and cost-effectiveness of this therapy.
Abstract